Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BYL719 in Recurrent or Metastatic SCCHN
NCT02145312Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Oct 2016
- Primary completion
- May 2019
- Countries
- 1
01
Overview
A Phase 2 trial of alpelisib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Yonsei University. Status: unknown.
02
Drugs
alpelisib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02145312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145312.